A common haplotype at the 5′ end of the<i>RET</i>proto‐oncogene, overrepresented in Hirschsprung patients, is associated with reduced gene expression

10.1086/302329

10.1073/pnas.97.1.268

10.1136/jmg.36.10.771

10.1136/jmg.37.8.572

10.1086/345466

10.1038/sj.ejhg.5201199

10.1677/jme.0.0290023

10.1038/ng998

Chakravarti A, 2001, The metabolic and molecular bases of inherited disease, 6231

10.1086/302618

10.1016/S0140-6736(02)08218-1

10.1093/hmg/ddg354

10.1038/ng868

10.1006/meth.2001.1261

10.1038/sj.ejhg.5200521

10.1086/342774

10.1136/gut.52.8.1154

10.1093/hmg/ddg246

10.1016/S0168-9525(01)02420-9

Pachnis V, 1993, Expression of the c‐RET proto‐oncogene during mouse embryogenesis, Development, 119, 1005, 10.1242/dev.119.4.1005

10.1016/S0022-3468(00)80031-7

10.1136/jmg.40.9.714

10.1038/367380a0

10.1002/(SICI)1098-1004(1997)9:3<243::AID-HUMU5>3.0.CO;2-8

Tsuzuki T, 1995, Spatial and temporal expression of the RET proto‐oncogene product in embryonic, infant and adult rat tissue, Oncogene, 10, 191